Hiroki Aida

Metabolic dysfunction‐associated steatotic liver disease (SLD) and alcohol‐associated liver disease, but not SLD without metabolic dysfunction, are independently associated with new onset of chronic kidney disease during a 10‐year follow‐up period

Kazuma Mori, Marenao Tanaka, Tatsuya Sato et al. · Hepatology Research · 2024 · 25 citations · Full text

Medicine, Nephrology, Clinical Nutrition +14

Incorporation of Metabolic Dysfunction‐Associated Steatotic Liver Disease in the Health Stage of Cardiovascular‐Kidney‐Metabolic Syndrome Improves Predictive Ability for Coronary Artery Disease in a Japanese General Population

Wataru Kawaharata, Marenao Tanaka, Tatsuya Sato et al. · Journal of the American Heart Association · 2025 · 13 citations · Full text

Medicine, Cardiology, Preventive Cardiology +15

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Is an Independent Risk Factor for the Development of Ischemic Heart Disease　― A 10-Year Cohort Study ―

Toshifumi Ogawa, Tatsuya Sato, Marenao Tanaka et al. · Circulation Reports · 2025 · 11 citations · Full text

Medicine, Cardiology, Internal Medicine +11

High Level of Estimated Small Dense Low-Density Lipoprotein Cholesterol as an Independent Risk Factor for the Development of Ischemic Heart Disease Regardless of Low-Density Lipoprotein Cholesterol Level　― A 10-Year Cohort Study ―

Keisuke Endo, Marenao Tanaka, Tatsuya Sato et al. · Circulation Journal · 2025 · 10 citations · Full text

Medicine, Cardiology, Health Sciences +17